Since publication of the first edition, Spasticity: Diagnosis and Management has been the defining reference and go-to source for physicians, therapists, and other healthcare providers who care for patients with spasticity. For this new updated edition, Dr. Brashear and a diverse team of specialists have come together to integrate new research, clinical trials, measurement tools, therapies, and other recent advances that reflect this evolving field. New chapters on neuromodulation, spasticity in cancer patients, spasticity management in long-term care facilities, and more broaden the scope of the new edition. This book remains the most comprehensive guide to diagnosis and management of spasticity in adults and children, and the revised second edition will continue to serve as an invaluable resource for professionals in any discipline who strive to provide quality care to spasticity patients.

About the Author

Allison Brashear, MD is Professor and Chair of the Department of Neurology at the Wake Forest University School of Medicine.

Contents

Chapter 1: Why Is Spasticity Treatment Important?
Chapter 2: Epidemiology of Spasticity in the Adult and Child
Chapter 3: Spasticity and Other Signs of the Upper Motor Neuron Syndrome
Chapter 4: Ancillary Findings Associated With Spasticity
Chapter 5: Measurement Tools and Treatment Outcomes in Patients With Spasticity
Chapter 6: Techniques and Scales for Measuring Spastic Paresis
Chapter 7: Assessment of Spasticity in the Upper Extremity
Chapter 8: Assessment of Lower Limb Spasticity and Other Consequences of the Upper Motor Neuron Syndrome
Chapter 9: Setting Realistic and Meaningful Goals for Treatment
Chapter 10: Chemoneurolysis With Phenol and Alcohol: A Dying Art That Merits Revival
Chapter 11: Botulinum Toxin in the Treatment of Lower Limb Spasticity
Chapter 12: Botulinum Toxin in the Treatment of Upper Limb Spasticity
Chapter 13: Guidance Techniques for Botulinum Toxin Injections: A Comparison
Chapter 14: Anatomical Correlation of Common Patterns of Spasticity
Chapter 15: The Role of Physical and Occupational Therapy in the Evaluation and Management of Spasticity
Chapter 16: Emerging Technologies in the Management of Upper Motor Neuron Syndromes
Chapter 17: Effects of Noninvasive Neuromodulation in Spasticity
Chapter 18: Pharmacologic Management of Spasticity: Oral Medications
Chapter 19: Intrathecal Baclofen for Spasticity
Chapter 20: Surgery in the Management of Spasticity
Chapter 21: Diagnostic Evaluation of Adult Patients With Spasticity
Chapter 22: Overview of Genetic Causes of Spasticity in Adults and Children
Chapter 23: Spasticity Due to Disease of the Spinal Cord: Pathophysiology, Epidemiology, and Treatment
Chapter 24: Spasticity Due to Multiple Sclerosis: Epidemiology, Pathophysiology, and Treatment
Chapter 25: Poststroke Spasticity Management with Botulinum Toxins and Intrathecal Baclofen
Chapter 26: Management of Brain Injury Related Spasticity
Chapter 27: Management of the Cancer Patient with Spasticity
Chapter 2S: Evaluation, Treatment Planning, and Nonsurgical Treatment of Cerebral Palsy
Chapter 29: Surgical Management of Spasticity in the Child with Cerebral Palsy
Chapter 30: Spasticity Management in Long-Term Care Facilities
Chapter 31: Economic Impact of Spasticity and Its Treatment